The numbers are still staggering. Every year, cancer affects 19 million new people worldwide, including 450,000 new cases and 160,000 deaths in France alone. Suffice it to say that if there is one sector in which medical research can be invested, it is oncology. The Gustave-Roussy Institute in Villejuif (Val-de-Marne) understands this well. The leading European cancer center continues to provide itself with the means to better treat this disease, better detect it and better prevent it.
The rest after this announcement
On January 23, management announced an investment of €150 million to create a 32,800 m² extension dedicated to research. “Construction will begin at the end of 2024 and delivery is scheduled for the end of 2026,” says Professor François Barlesi, director general of the institute. This will increase our area dedicated to research by 30% and double the number of researchers, which will increase to 60 teams. »
Source: Le Parisien
I am a highly experienced and well-connected journalist, with a focus on healthcare news. I have worked for several major news outlets, and currently work as an author at 24 news recorder. My work has been featured in many prestigious publications, and I have a wide network of contacts in the healthcare industry. I am highly passionate about my work, and strive to provide accurate and timely information to my readers.
